Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
58.30
+8.60 (17.30%)
Apr 29, 2026, 1:36 PM CST

Puriblood Medical Revenue

Puriblood Medical had revenue of 40.25M TWD in the half year ending June 30, 2025, with 24.67% growth. This brings the company's revenue in the last twelve months to 117.35M, down -7.28% year-over-year. In the year 2024, Puriblood Medical had annual revenue of 110.67M, down -11.65%.

Revenue (ttm)
117.35M
Revenue Growth
-7.28%
P/S Ratio
6.03
Revenue / Employee
2.67M
Employees
44
Market Cap
707.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024110.67M-14.60M-11.65%
Dec 31, 2023125.27M-12.17M-8.86%
Dec 31, 2022137.44M82.86M151.79%
Dec 31, 202154.59M15.94M41.25%
Dec 31, 202038.65M35.55M1,149.06%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sofiva Genomics 385.71M
Kim Forest Enterprise 549.14M
Pharmigene 149.25M
Genetics Generation Advancement 603.11M
Welgene Biotech 375.94M
DIVA Laboratories 868.84M
BIONET 1.24B
Revenue Rankings